Protalix BioTherapeutics
PLX
#8625
Rank
C$0.18 B
Marketcap
$2.53
Share price
1.15%
Change (1 day)
5.91%
Change (1 year)

Protalix BioTherapeutics (PLX) - Net assets

Net assets on the balance sheet as of September 2024 : C$46.57 Million

According to Protalix BioTherapeutics 's latest financial reports the company has C$46.57 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$44.52 M-408.38%
2022-12-31$-C$14.44 Million87.69%
2021-12-31$-C$7.7 Million-77.69%
2020-12-31$-C$34.48 Million-62.46%
2019-12-31$-C$91.85 Million27.5%
2018-12-31$-C$72.04 Million94.5%
2017-12-31$-C$37.04 Million176.78%
2016-12-31$-C$13.39 Million-188.71%
2015-12-31$C$15.08 M-123.38%
2014-12-31$-C$64.53 Million124.95%
2013-12-31$-C$28.69 Million759.27%
2012-12-31$-C$3.34 Million-87.42%
2011-12-31$-C$26.53 Million134.36%
2010-12-31$-C$11.32 Million-167.73%
2009-12-31$C$16.71 M-69.01%
2008-12-31$C$53.92 M-15.13%
2007-12-31$C$63.53 M124.7%
2006-12-31$C$28.27 M298.44%
2005-12-31$C$7.09 M1093.54%
2004-12-31$C$0.59 M-30.07%
2003-12-31$C$0.85 M-32.38%
2002-12-31$C$1.25 M-16.55%
2001-12-31$C$1.5 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$0.25 B 451.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.90 B 8,282.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$132.90 B 285,246.98%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.16 B 19,581.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel